Affinergy Inc.
This article was originally published in Start Up
Executive Summary
Affinergy has--patented and in the freezer--peptide binders that stick specifically to the common materials of which medical implants are made, for example, collagen, titanium and stainless steel. These are the starting point for the company's device coating platform. The other part of the biocoating, which attaches to the device-binding peptide by a linker, is a peptide that binds to a specific protein or cell type of interest to a partner.
You may also be interested in...
Biocoatings: Not Just the Icing on the Cake
The successful commercialization of drug-eluting stents (DES) has done much to pave the way for the biocoating industy. DES not only helped establish a new regulatory body to facilitate device-drug reviews, the FDA Office of Combination Products, they also proved that biocoated devices could take market share from uncoated products, command premium pricing and premium reimbursement.
ASA Finds 'Irresponsible' Weight Loss Ad Difficult To Stomach
Vision Healthcare’s Sensilab pulled Facebook advertisements for its weight loss supplements after UK regulator the Advertising Standards Authority launched an investigation into whether the marketing, which featured slim models, was "irresponsible."
Obituary: Wolfgang Ollig, Stada CFO
The death has been announced of Stada’s chief financial officer, Wolfgang Ollig.